EA3191 A Phase II Randomized Trial of Adjuvant Therapy with Pembrolizumab after Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma with High Risk Features
- Phase II
- Trial Category: Head and Neck
Contact(s)
Mary Beth Wilwerding, RN Admin@NEcancertrials.com
Location(s)
Available at Nebraska Methodist Estabrook Cancer Center
Interested in More Information?
Please fill out the form below. Someone will get back to you as soon as possible.
"*" indicates required fields